Insiders Kiora Pharmaceuticals, Inc.

Equities

KPRX

US49721T3095

Market Closed - Nasdaq Other stock markets 21:00:00 13/05/2024 BST			5-day change	1st Jan Change
0.5097 ^USD	+4.83%		-2.17%	-2.43%

05-10	Earnings Flash (KPRX) KIORA PHARMACEUTICALS Posts Q1 Revenue $16M	MT
03-25	Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kiora Pharmaceuticals, Inc. Announces Board Changes	21/09/23	CI
Kiora Pharmaceuticals, Inc. Appoints Carmine Stengone as an Independent Director	01/08/23	CI
Kiora Pharmaceuticals, Inc. Appoints Melissa Tosca as Executive Vice President of Finance	13/09/22	CI
Kiora Pharmaceuticals, Inc. Announces Brian M. Strem Will Assume Role of its Principal Financial and Accounting Officer	21/06/22	CI
Kiora Pharmaceuticals, Inc. Announces Resignation of Susan L. Drexler as Interim Chief Financial Officer	21/06/22	CI
Kiora Pharmaceuticals, Inc. Appoints Susan L. Drexler as the Principal Accounting Officer and Principal Financial Officer	26/04/22	CI
Kiora Pharmaceuticals, Inc. Appoints Susan L. Drexler as Interim Chief Financial Officer	26/04/22	CI
Kiora Pharmaceuticals, Inc. Announces Executive Changes	23/03/22	CI
First Wave BioPharma Names Sarah Romano as Chief Financial Officer	01/03/22	MT
Kiora Pharmaceuticals, Inc. Appoints Michael Meluzio as Principal Financial Officer and Principal Accounting Officer	28/02/22	CI
Kiora Pharmaceuticals, Inc. Appoints Michael Meluzio as Principal Financial Officer and Principal Accounting Officer	28/02/22	CI
Kiora Pharmaceuticals, Inc. Announces Resignation of Sarah Romano as Chief Financial Officer, Effective February 25, 2022	14/02/22	CI
Kiora Pharmaceuticals, Inc. Announces Executive Changes	01/02/22	CI
Kiora Pharmaceuticals, Inc. Appoints David Hollander to its Board of Director	15/12/21	CI
EyeGate Pharmaceuticals, Inc. has Changed its Name to Kiora Pharmaceuticals, Inc	08/11/21	CI
EyeGate Pharmaceuticals, Inc. Appoints Eric J. Daniels as Its Chief Development Officer	26/10/21	CI
Eyegate Pharmaceuticals, Inc. Announces Management Changes	04/08/21	CI
Insider Trends: Insider Adds to Selling Trend at EyeGate Pharmaceuticals	03/08/21	MT
EyeGate Pharmaceuticals, Inc. Appoints Brian M. Strem, Ph.D. as President	26/07/21	CI
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, as Chief Executive Officer	26/07/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Kiora Pharmaceuticals, Inc.

Equities

KPRX

US49721T3095

Insiders

Filters